Evidence map›Paper›PMID 25076135›Full record

ArticlePloS one2014

Nuclease-assisted suppression of human DNA background in sepsis.

Yajing Song, Christian G Giske, Patrik Gille-Johnson, Olof Emanuelsson, Joakim Lundeberg, Peter Gyarmati

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. The Microbiota in Hematologic Malignancies.Current treatment options in oncology · 2020
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yajing SongRoyal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
Christian G GiskeKarolinska Institutet, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden; Karolinska University Hospital, Department of Clinical Microbiology, Stockholm, Sweden.
Patrik Gille-JohnsonDivision of Infectious Diseases, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Olof EmanuelssonRoyal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
Joakim LundebergRoyal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
Peter GyarmatiRoyal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden; Karolinska Institutet, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden; Karolinska University Hospital, Department of Clinical Microbiology, Stockholm, Sweden.
Science for Life Laboratory · SEKarolinska Institutet · SEKarolinska University Hospital · SEKTH Royal Institute of Technology · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a severe medical condition characterized by a systemic inflammatory response of the body caused by pathogenic microorganisms in the bloodstream. Blood or plasma is typically used for diagnosis, both containing large amount of human DNA, greatly exceeding the DNA of microbial origin. In order to enrich bacterial DNA, we applied the C0t effect to reduce human DNA background: a model system was set up with human and Escherichia coli (E. coli) DNA to mimic the conditions of bloodstream infections; and this system was adapted to plasma and blood samples from septic patients. As a consequence of the C0t effect, abundant DNA hybridizes faster than rare DNA. Following denaturation and re-hybridization, the amount of abundant DNA can be decreased with the application of double strand specific nucleases, leaving the non-hybridized rare DNA intact. Our experiments show that human DNA concentration can be reduced approximately 100,000-fold without affecting the E. coli DNA concentration in a model system with similarly sized amplicons. With clinical samples, the human DNA background was decreased 100-fold, as bacterial genomes are approximately 1,000-fold smaller compared to the human genome. According to our results, background suppression can be a valuable tool to enrich rare DNA in clinical samples where a high amount of background DNA can be found.

Indexed as

CalibrationDeoxyribonucleasesDNAEscherichia coliEscherichia coli InfectionsGenes, BacterialHumansMolecular Diagnostic TechniquesReal-Time Polymerase Chain ReactionReference StandardsSensitivity and SpecificitySepsisSystemic Inflammatory Response SyndromeDeoxyribonucleasesDNA

Identifiers

PMID25076135
PMCPMC4116218
OpenAlexW2050956212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.